Skip to content
ENP69: Biosimilar Insulin episode artwork

Apr 12, 2023 16 min

ENP69: Biosimilar Insulin

from Endocrine News Podcast

In this episode, we hear about biosimilar insulin: its safety, efficacy, what sets it apart from biologic insulin, and when it should be considered for use. Host Aaron Lohr talks with Irl Hirsch, MD, professor of medicine at the University of Washington Medicine Diabetes Institute. This episode is made possible through an unrestricted, educational grant from Viatris. Show notes are available at https://www.endocrine.org/podcast/enp69-biosimilar-insulin — for helpful links or to hear more podcast episodes, visit https://www.endocrine.org/podcast

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

ENP69: Biosimilar Insulin

0:00 16:27

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Endocrine News Podcast?

This episode is 16 minutes long.

When was this Endocrine News Podcast episode published?

This episode was published on April 12, 2023.

Can I download this Endocrine News Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.